Soleno Therapeutics (SLNO) Prepaid Assets (2013 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Prepaid Assets of $6.3 million for Q1 2026, down 66.62% year-over-year from $19.0 million in Q1 2025, and down 10.97% quarter-over-quarter from $7.1 million in Q4 2025.
Soleno Therapeutics (SLNO) Prepaid Assets (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Prepaid Assets for 14 consecutive years, with $6.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 66.62% year-over-year to $6.3 million; the TTM figure through Mar 2026 stood at $6.3 million (down 66.62% YoY), while the FY2025 annual figure was $7.1 million, up 189.97% from the prior year.
- Prepaid Assets fell to $6.3 million in Q1 2026 per SLNO's latest filing, from $7.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $19.0 million in Q1 2025 and bottomed at $821000.0 in Q3 2022.
- Historically, Prepaid Assets has averaged $3.2 million across 5 years, with a median of $1.4 million in 2024.
- Annual changes were most pronounced in 2025 — Prepaid Assets surged 1088.28% — and 2026, when it sank 66.62%.
- Soleno Therapeutics' Prepaid Assets stood at $1.0 million in 2022, then surged by 60.48% to $1.7 million in 2023, then jumped by 46.21% to $2.5 million in 2024, then jumped by 189.97% to $7.1 million in 2025, then declined by 10.97% to $6.3 million in 2026.
- Business Quant data shows SLNO's Prepaid Assets at $6.3 million in Q1 2026, $7.1 million in Q4 2025, and $3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.33 Mn |
| Dec 31, 2025 | 7.11 Mn |
| Sep 30, 2025 | 3.74 Mn |
| Jun 30, 2025 | 2.97 Mn |
| Mar 31, 2025 | 18.97 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 1.25 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 821,000.00 |
| Jun 30, 2022 | 824,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.12 Mn |
| Sep 30, 2021 | 702,000.00 |
| Jun 30, 2021 | 948,000.00 |